1. Immunology/Inflammation
  2. Interleukin Related
  3. Dupilumab

Dupilumab  (Synonyms: REGN-668; SAR-231893)

Art. -Nr.: HY-P9926 Reinheit: ≥99.2%
Technical Support

Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr. : 1190264-60-8

Größe Preis Verfügbarkeit Menge
1 mg Auf Lager
5 mg Auf Lager
10 mg Auf Lager
25 mg Auf Lager
50 mg Auf Lager
100 mg Auf Lager
200 mg   Angebot einholen  
500 mg   Angebot einholen  

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

This product is a controlled substance and not for sale in your territory.

Kundenbewertung

Based on 6 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Dupilumab purchased from MedChemExpress. Usage Cited in: ACS Nano. 2025 Sep 16;19(36):32361-32373.  [Abstract]

    Dupilumab (5 μg/mL, 48 h). Cytokine concentrations measured in culture supernatants following drug treatments.

    Dupilumab purchased from MedChemExpress. Usage Cited in: ACS Nano. 2025 Sep 16;19(36):32361-32373.  [Abstract]

    Representative images of spheroids subjected to microfluidic deformation analysis, comparing untreated control, antifibrotic drug NTD, and anti-interleukin drugs TCZ, STX, DUP (Dupilumab; 5 μg/L; 48 h), and TRA.

    Dupilumab purchased from MedChemExpress. Usage Cited in: ACS Nano. 2025 Sep 16;19(36):32361-32373.  [Abstract]

    Confocal fluorescence images showing the expression of collagen-1 and α-SMA in spheroids treated with NTD, TCZ, STX, DUP (Dupilumab, 5 μg/L, 48 h), and TRA.

    Dupilumab purchased from MedChemExpress. Usage Cited in: Allergy. 2025 Oct 22.  [Abstract]

    Comparison of mRNA levels for SCGB1A1, FOXJ1, and MUC5AC in untreated, IL-13, AS1517499, and Dupilumab (10 μM, 6 h)-treated HNECs using RT-qPCR.

    Dupilumab purchased from MedChemExpress. Usage Cited in: Allergy. 2025 Oct 22.  [Abstract]

    Dupilumab (10 μM, 6 h). Flow cytometry analysis of changes in SCGB1A1+βIV­tubulin and SCGB1A1+MUC5AC+ clusters across treatment groups.
    • Biologische Aktivität

    • Reinheit & Dokumentation

    • Verweise

    • Kundenbewertung

    Beschreibung

    Dupilumab (REGN-668) is a fully human mAb to IL-4 receptor α (IL-4Rα) that inhibits both IL-4 and IL-13 signaling, markedly improved moderate-to-severe atopic dermatitis[1].

    Isotype

    Human IgG4 kappa

    Recommend Isotype Controls
    Species Reactivity

    Human

    IC50 & Target[1]

    IL-2

     

    IL-4

     

    IL-13

     

    In Vitro

    Dupilumab suppressed mRNA expressions of genes related to activation of T cells, DCs, eosinophils, inflammatory pathways, and TH2-inducing chemokines in skin lesions. No significant reduction in IL-17A or IL-22 levels is detected, but large reductions in expression of IL-17–related genes, such as elafin (PI3), IL23p19/IL23A, and S100A8 and trends for suppression (CXCL1 and S100A7) are found with 300 mg of Dupilumab[1].
    Major suppressions of hyperplasia-related genes (eg, K16) and reductions in expression of S100A genes are evident with 300 mg of Dupilumab by using microarrays and qRT-PCR. The changes in other critical epidermal alterations in severe atopic dermatitis (AD) skin are also measured, including significant increases in claudin and lipid product levels with 300 mg of Dupilumab. A trend of dose-dependent increases in expression of differentiation genes (LOR and FLG) is observed after adjusting for suppression of epidermal hyperplasia, as demonstrated by K16 reductions with Dupilumab[1].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    Klinische Studie
    Gene ID

    3566  [NCBI]

    Accession
    Application

    ELISA, FACS, Functional assay

    Conjugated

    Unconjugated

    Reconsititution

    The product can be reconstituted/diluted with sterile PBS or saline.

    Molekulargewicht

    147 kDa

    CAS. Nr.
    Appearance

    Liquid

    Color

    Colorless to light yellow

    SMILES

    [Dupilumab]

    Formulation

    Please refer to the lot-specific COA for specific buffer information.

    Speicherung

    Please store the product under the recommended conditions in the Certificate of Analysis.

    Format
    • Human IgG4 kappa
    Biological Activity
    • Flow cytometry analysis of Raji cells labelling IL-4Rα with Dupilumab at 100nM (Red). Goat anti human IgG Fc(Alexa Fluor488) was used as the secondary antibody at 1/400 dilution. Isotype control - human IgG (Blue). Unlabeled control - Unlabelled cells (Gray).
    Reinheit & Dokumentation

    Purity: ≥99.2%

    Verweise
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molaritätsrechner

    • Verdünnungsrechner

    Die Formel zur Berechnung von Molaritäten

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)

    Diese Gleichung wird häufig abgekürzt als: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    Ihre kürzlich angesehenen Produkte:

    Online-Anfrage

    Your information is safe with us. * Required Fields.

    Produktname

     

    Requested Quantity *

    Name des Antragstellers *

     

    Anrede

    E-Mail-Addresse *

     

    Telefonnummer *

    Department

     

    Name der Organisation *

    City

    Bundesland

    Country or Region *

         

    Bemerkungen

    Massenanfrage

    Inquiry Information

    Produktname:
    Dupilumab
    Art. -Nr.:
    HY-P9926
    Menge:
    MCE Japan Authorized Agent: